MorphoSys AG

MORNASDAQHealthcare

$18.96

+$0.45(+2.43%)

Market Cap$2.9B

P/E Ratio—

52W High$19.5

52W Low$4.185

Avg Volume83K

Open$18.38

Beta0.66

Net Income Financials Revenue

MorphoSys AG (MOR) Net Income & Profit History

Annual & trailing net income, net margin, YoY change, and peer profitability context.

MOR · net income · updated Jun 9, 2026

Core profitability metrics

MOR · net income · margin · TTM · CAGR

Net income was −$189.7M for FY2023 (fiscal year ending 2023-12-31), down 25.6% year-over-year. Net profit margin was -79.6%. Based on available data, MorphoSys AG has been profitable since at least 2009.

FY2023 Net Income−$189.7M▼ -25.6% YoY

Trailing 12M (TTM)−$460.3Mtrailing 4 quarters sum

Net Profit Margin-79.6%−$189.7M ÷ $238.3M

YoY Change-25.6%—

5-Year CAGRN/AN/A — contains loss years

FormulaNet Margin = Net Income ÷ Revenue × 100TTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /income-statement · US GAAP · USDUpdated: Jun 9, 2026

Annual net income history

Net Income (bars) · Net Profit Margin % (line)

Net IncomeNet LossNet Margin %★ First Profit: 2009

▸ FMP /income-statement · Annual · MOR net income history · MOR profit margin

Annual net income data

MOR · net income history · annual / quarterly

Fiscal YearNet IncomeYoY ChangeNet MarginRevenue

FY2023Loss−$189.7M▼ 25.6%-79.6%$238.3M

FY2022Loss−$151.1M▲ +70.6%-54.3%$278.3M

FY2021Loss−$514.5M▼ 625.6%-286.5%$179.6M

FY2020$97.9M▲ +195.0%29.9%$327.7M

FY2019Loss−$103.0M▼ 83.4%-143.6%$71.8M

Net income vs peers (Healthcare)

MOR vs peers · net income

#CompanyNet IncomeYoYNet MarginRelative

MorphoSys AGYOU

MOR

−$189.7M-25.6%-79.6%

Loss

Eli Lilly and Company

LLY

$20.64B+94.9%31.7%

77%

UnitedHealth Group Incorporated

Healthcare · Sorted by Net Income · FMP /income-statementFull Net Income Rankings →

About Net Income & Methodology

MorphoSys AG (MOR) reported net income of −$189.7M for FY2023 (fiscal year ending 2023-12-31), down 25.6% year-over-year. The net profit margin was -79.6% — meaning the company kept $-0.80 of every dollar of revenue as profit.

Based on available data, MorphoSys AG has been profitable since at least 2009. Net income reached a peak of $97.9M in FY2020. Data available for 15 fiscal years.

MorphoSys AG's net profit margin was -79.6% for FY2023, based on the latest annual results.

Investors sometimes search for "MorphoSys AG net worth" — the company's market capitalization is a separate figure from MOR net income. Data sourced from FMP /income-statement · US GAAP · USD.

Figures tie to SEC 10-K/10-Q and FMP /income-statement where noted.

Revenue Financial statements Earnings Forecast Price history Market cap Free cash flow

Frequently asked questions

MOR net income · 4 questions

MorphoSys AG is not currently profitable on an annual basis. The company reported a net loss of $189.7M for FY2023.

is MOR profitabledoes MOR make a profitMOR profitabilityMOR profitable company

▸ Source: FMP /income-statement · GAAP · MorphoSys AG · MorphoSys AG SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 9, 2026